Abiopharma

News list

Director Wiadrowski David 🟢 acquired 4.8K shares of Life360, Inc. (LIF) Transaction Date: May 29, 2026 | Filing ID: 000104

Full text

News bot June 2, 2026, 9:59 p.m.
🔍 Wiadrowski David (Director)

Company: Life360, Inc. (LIF)

Report Date: 2026-05-29
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 4,816
Detailed Transactions and Holdings:
- Acquired 4,816 shares of Common Stock (Direct)
  Date: 2026-05-29 | Code: A | equity_swap_involved: 0 | shares_owned_after: 44,495.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents the grant of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 1/4th of the RSUs will vest quarterly from May 15, 2026, subject to the Reporting Person's continuous service through each vest date.
- F2: Includes 5,554 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- F3: Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.